📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease. (2022)

First Author: Douglas LEJ

Attributed to: Queen’s P2D 2017: Building on Successful Foundations and Developing New Approaches funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2022.02.001

PubMed Identifier: 35202587

Publication URI: http://europepmc.org/abstract/MED/35202587

Type: Journal Article/Review

Volume: 29

Parent Publication: Cell chemical biology

Issue: 6

ISSN: 2451-9448